Friday 6 November 2026
Export CDNA’s income statement to Excel — free account
CareDx, Inc.
CDNA Healthcare Diagnostics & Research
CareDx, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $379.8 million, up 13.8% from fiscal 2024.
- Revenue
- +39.3%
- EPS
- +1,133.3%
- Free cash flow
- −68.6%
Quarter to September 2026, against a year earlier
78.50
2.17
+2.84%
Follow CDNA
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(6.27%) | (2.36%) | 29.49% | 33.04% | |
Piotroski F-Score |
5 | 6 | 8 | 7 | |
| (4.72%) | (1.82%) | 22.72% | 23.96% | ||
ROIC |
(15.28%) | (8.02%) | 130.06% | 33.56% | |
Return on Tangible Assets |
(10.66%) | (3.67%) | 30.64% | 61.45% | |
Average Days of Receivables |
40.97 | 39.42 | 27.39 | 35.03 | |
Free Cash Flow per Share |
0.65 | 1.27 | 1.65 | 1.15 | |
Free Cash Flow |
34.55 | 64.85 | 84.71 | 59.76 | |
Capital Expenditures |
(7.48) | (8.10) | (8.95) | (9.26) | |
| Other line items | |||||
Cash ROIC |
7.19% | 12.95% | 10.60% | 8.32% | |
Accounts Receivable Turnover |
7.08 | 7.11 | 9.01 | 10.41 | |
Accounts Payable Turnover |
13.95 | 14.99 | 13.92 | 12.89 | |
Inventory Turnover |
5.33 | 5.21 | 7.72 | 7.71 | |
Average Days of Payables |
29.58 | 25.76 | 25.71 | 27.32 | |
Days of Inventory on Hand |
79.09 | 75.03 | 18.91 | 23.11 | |
Tax Rate |
0.01 | 0.02 | (0.04) | 0.04 | |
Research and Development Expense of Revenue |
18.81% | 18.00% | 17.43% | 16.97% | |
Selling, General and Administrative Expense of Revenue |
55.35% | 54.58% | 54.07% | 53.17% | |
Share Based Compensation of Revenue |
9.18% | 8.66% | 8.07% | 7.68% | |
Operating CF/Net income |
(1.97) | (8.90) | 0.84 | 0.54 | |
Depreciation/Fixed assets |
0.66 | 0.67 | 0.82 | 0.92 | |
Capex/Depreciation |
(0.35) | (0.37) | (0.41) | (0.37) | |
Revenue per Share |
7.13 | 8.07 | 8.90 | 9.54 | |
Operating CF per Share |
0.79 | 1.43 | 1.82 | 1.32 | |
Capex per Share |
(0.14) | (0.16) | (0.17) | (0.18) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 5 Nov 2026